91 related articles for article (PubMed ID: 30082156)
21. High tumor mast cell density is associated with longer survival of colon cancer patients.
Mehdawi L; Osman J; Topi G; Sjölander A
Acta Oncol; 2016 Dec; 55(12):1434-1442. PubMed ID: 27355473
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance and prognostic value of Nek2 protein expression in colon cancer.
Lu L; Zhai X; Yuan R
Int J Clin Exp Pathol; 2015; 8(11):15467-73. PubMed ID: 26823916
[TBL] [Abstract][Full Text] [Related]
23. High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients.
Chen X; Sun K; Jiao S; Cai N; Zhao X; Zou H; Xie Y; Wang Z; Zhong M; Wei L
Sci Rep; 2014 Dec; 4():7481. PubMed ID: 25500546
[TBL] [Abstract][Full Text] [Related]
24. Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis.
Wu SW; Ma CC; Li WH
Diagn Pathol; 2015 Aug; 10():144. PubMed ID: 26276145
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
26. FRZB up-regulation is correlated with hepatic metastasis and poor prognosis in colon carcinoma patients with hepatic metastasis.
Shen Y; Zhang F; Lan H; Chen K; Zhang Q; Xie G; Teng L; Jin K
Int J Clin Exp Pathol; 2015; 8(4):4083-90. PubMed ID: 26097596
[TBL] [Abstract][Full Text] [Related]
27. Ubiquitin-like with PHD and ring finger domains 2 is a predictor of survival and a potential therapeutic target in colon cancer.
Lu S; Yan D; Wu Z; Jiang T; Chen J; Yuan L; Lin J; Peng Z; Tang H
Oncol Rep; 2014 Apr; 31(4):1802-10. PubMed ID: 24573556
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
[TBL] [Abstract][Full Text] [Related]
29. Elevated Expression of DLG1 Is Associated with Poor Prognosis in Patients with Colorectal Cancer.
Zhu GD; OuYang S; Liu F; Zhu ZG; Jiang FN; Zhang B
Ann Clin Lab Sci; 2017 Nov; 47(6):657-662. PubMed ID: 29263038
[TBL] [Abstract][Full Text] [Related]
30. Surtuin 1 as a potential prognostic biomarker in very elderly patients with colorectal cancer.
Lee GJ; Jung YH; Kim TJ; Chong Y; Jeong SW; Lee IK; Woo IS
Korean J Intern Med; 2021 Mar; 36(Suppl 1):S235-S244. PubMed ID: 32605336
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
[TBL] [Abstract][Full Text] [Related]
32. The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3.
Miller TJ; McCoy MJ; Hemmings C; Bulsara MK; Iacopetta B; Platell CF
Pathology; 2017 Dec; 49(7):721-730. PubMed ID: 29102042
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of chemerin expression in colorectal cancer: A detailed analysis based on histological components and meta-analysis.
Oh IH; Pyo JS; Min KW; Kim OZ; Son BK
Pathol Res Pract; 2023 Nov; 251():154876. PubMed ID: 37898040
[TBL] [Abstract][Full Text] [Related]
34. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
35. High expression of AT-rich interactive domain 3A (ARID3A) is associated with good prognosis in colorectal carcinoma.
Song M; Kim H; Kim WK; Hong SP; Lee C; Kim H
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S481-9. PubMed ID: 24366420
[TBL] [Abstract][Full Text] [Related]
36. High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancer.
Yan X; Yan L; Zhou J; Liu S; Shan Z; Jiang C; Tian Y; Jin Z
Int J Clin Exp Pathol; 2014; 7(12):8715-23. PubMed ID: 25674237
[TBL] [Abstract][Full Text] [Related]
37. Prognostic and clinical value of Sirt1 expression in gastric cancer: A systematic meta-analysis.
Jiang B; Chen JH; Yuan WZ; Ji JT; Liu ZY; Wu L; Tang Q; Shu XG
J Huazhong Univ Sci Technolog Med Sci; 2016 Apr; 36(2):278-284. PubMed ID: 27072976
[TBL] [Abstract][Full Text] [Related]
38. Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.
Meng H; Li W; Boardman LA; Wang L
BMC Cancer; 2018 Apr; 18(1):433. PubMed ID: 29661177
[TBL] [Abstract][Full Text] [Related]
39. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.
Duncan TJ; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
World J Surg Oncol; 2007 Mar; 5():31. PubMed ID: 17349047
[TBL] [Abstract][Full Text] [Related]
40. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
